Insmed Earnings & Forecasts

Insmed (INSM) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

분기별 실적 서프라이즈 금액

회계 분기	보고된 날짜	실제 EPS	예상 EPS	놀라다 %
Q2	Aug 6, 2026	$-0.06	$-0.74	91.9 %
Q1	May 7, 2026	$-0.76	$-0.98	22.4 %
Q4	Feb 19, 2026	$-1.54	$-1.13	-36.3 %
Q3	Oct 30, 2025	$-1.75	$-1.35	-29.6 %

Quarterly Revenue (Billions)

분기별 수익 깜짝 금액

회계 분기	보고된 날짜	실제 수익	예상 수익	놀라다 %
Q2	Aug 6, 2026	$425.49M	$389.26M	9.31 %
Q1	May 7, 2026	$305.96M	$302.26M	1.23 %
Q4	Feb 19, 2026	$263.84M	$263.93M	-0.03 %
Q3	Oct 30, 2025	$142.34M	$115.15M	23.6 %

Insmed Guidance

Insmed (INSM)는 8월 6, 2026에 fiscal year 2026에 대한 가이던스를 마지막으로 발표했습니다. 회사는 해당 기간의 매출을 $1.7B - $1.87B 범위로 예상했습니다.

이전 가이던스와 비교하여 Insmed는 매출 전망치를 이전 범위인 상향 조정됨에서 $1.45B - $1.47B로 상향 조정했습니다.

Insmed은 16과 5월 4, 2023 사이에 8월 6, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 8 times, reflecting management's growing confidence in business performance.

Recent Earnings Results

Metric	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Earnings Per Share (Non-GAAP)
Estimate	$-0.74	$-0.98	$-1.13	$-1.35
Actual	$-0.06	$-0.76	$-1.54	$-1.75
Surprise	+91.9%	+22.4%	-36.3%	-29.6%
Revenue
Estimate	$389.3M	$302.3M	$263.9M	$115.2M
Actual	$425.5M	$306.0M	$263.8M	$142.3M
Surprise	+9.31%	+1.23%	-0.03%	+23.6%

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q3 '26E	Q4 '26E	Q1 '27E	Q2 '27E
Earnings Per Share (Non-GAAP)
Consensus	$-0.36	$-0.31	$-0.25	$0.03
Revenue
Consensus	$500.5M	$566.4M	—	—

More with Benzinga EdgeGet Access

Earnings & Guidance News

PRO
Insmed Q2 EPS $(0.06) Beats $(0.73) Estimate, Sales $425.486M Beat $392.836M Estimate

Insmed (NASDAQ:INSM) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.73) by 91.78 percent. This is a 96.47 percent increase over losses of $(1.70) per share from the same

Benzinga Newsdesk

PRO
Insmed Raises FY2026 Sales Guidance from $1.450B-$1.470B to $1.700B-$1.870B vs $1.705B Est

Insmed (NASDAQ:INSM) raises FY2026 sales outlook from $1.450 billion-$1.470 billion to $1.700 billion-$1.870 billion vs $1.705 billion estimate.

Benzinga Newsdesk

Nasdaq 100 Climbs Records, Oil Extends Drop As Iran Weighs Hormuz Deal: Stock Market Today

U.S. stocks drifted near records Thursday as oil slipped on Iran-Hormuz peace hopes. Coinbase, Airbnb and CoreWeave on deck after the close.

Piero Cingari

PRO
Insmed Affirms FY2026 Sales Guidance of $1.450B-$1.470B vs $1.699B Est

Insmed (NASDAQ:INSM) affirms FY2026 sales outlook from $1.450 billion-$1.470 billion to $1.450 billion-$1.470 billion vs $1.699 billion estimate.

Benzinga Newsdesk

PRO
Insmed Q1 EPS $(0.76) Beats $(0.97) Estimate, Sales $305.964M Beat $303.298M Estimate

Insmed (NASDAQ:INSM) reported quarterly losses of $(0.76) per share which beat the analyst consensus estimate of $(0.97) by 21.65 percent. This is a 46.48 percent increase over losses of $(1.42) per share from the same

Benzinga Newsdesk

PRO
CORRECTION: Insmed Sees FY2026 Sales $1.450B-$1.470B vs $1.372B Est

Benzinga Newsdesk

Insmed Inc